Macasasa, Arlene S.

HRN: 26-91-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/10/2025
08/16/2025
IV
600mg
Q8
Infected Wound
Checking Initial Appropriateness 
08/10/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/10/2025
08/16/2025
IV
1.5g
Q8
Infected Wound
Checking Initial Appropriateness 
08/13/2025
CEFTAZIDIME 1GM (VIAL)
08/13/2025
08/20/2025
IV
2 Gram
OD
Infected Wound
Checking Initial Appropriateness 
08/15/2025
CEFTRIAXONE 1G (VIAL)
08/15/2025
08/21/2025
IV
2gm
OD
Infected Wound
Checking Initial Appropriateness 
08/21/2025
CEFTRIAXONE 1G (VIAL)
08/21/2025
09/04/2025
IVTT
2g
OD
Infected Wound
Checking Initial Appropriateness 
08/25/2025
MUPIROCIN 2%, 15G (TUBE)
08/25/2025
08/31/2025
TOPICAL
2g
Twice A Day
Infected Wound Left Foot
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: